Jump to navigation
UA researchers have found that children who attended day care during the first six months of life, or had two or more older siblings, were less allergic at ages 6 and 11, and half as likely to develop asthma later in life than children who did not attend day care or had no older siblings.
The Arizona Health Sciences Center (AHSC) is launching a national search to fill the dual position of vice president for Health Sciences and dean of the College of Medicine.
Dr. Michael S. Gordon, has been named associate dean of research for the Phoenix Campus of the University of Arizona Health Sciences Center. Gordon is recognized for his work in new drug discovery, most notably biologic therapy and anti-angiogenic drugs that block new blood vessel growth to starve tumors.
More than 34,000 students will start classes at the University of Arizona on Monday, Aug. 21. They won't have to look far to find presidents and provosts on campus.
University Medical Center (UMC) has a new, more effective test to detect cervical cancer and pre-cancers.
University Medical Center will offer free, fast, painless screenings for peripheral vascular disease on Saturday, Sept. 23, as part of the Legs for Life National Screening Program.
Teens between the ages of 14 and 17 who smoke cigarettes and are interested in quitting can call the free University of Arizona "Teen Quit Smoking Study" number at 1-877-850-1080 to enroll. The National Cancer Institute has sponsored The University of Arizona College of Public Health to evaluate Zyban( in conjunction with healthy lifestyle counseling )as an aid to help teens to quit smoking.
Researchers at the University of Arizona Sarver Heart Center have received an $8.8 million grant to fund five projects dealing with embryonic heart development.
Dr. Scot Ebbinghaus, assistant professor of medicine at the Arizona Cancer Center, received the Robert S. Flinn Clinical Faculty Research Fellowship award from the Flinn Foundation.
The Bone Marrow Transplantation Program at University Medical Center has received full, three-year accreditation from the Foundation for the Accreditation of Hematopoetic Cell Therapy.
